Sensus Healthcare, Inc. (NASDAQ:SRTS) Q3 2022 Earnings Conference Call November 3, 2022 4:30 PM ET
Company Participants
Kim Golodetz - Investor Relations
Joe Sardano - Chairman and Chief Executive Officer
Michael Sardano - President and General Counsel
Javier Rampolla - Chief Financial Officer
Conference Call Participants
Scott Henry - Roth Capital
Yi Chen - H.C. Wainwright
Benjamin Haynor - Alliance Global Partners
Anthony Vendetti - Maxim Group
Operator
Hello and welcome to the Sensus Healthcare Third Quarter 2022 Earnings Conference Call. [Operator Instructions] Please note this event is being recorded. I would now like to turn the conference over to Kim Golodetz with LHA Investor Relations. Please go ahead, ma’am.
Kim Golodetz
Thank you. This is Kim Golodetz with LHA. Thank you all for participating in today’s call. Joining me from Sensus Healthcare are Joe Sardano, Chairman and Chief Executive Officer; Michael Sardano, President and General Counsel; and Javier Rampolla, Chief Financial Officer.
As a reminder, some of the matters that will be discussed during today’s call contain forward-looking statements within the meaning of federal securities laws. All statements other than historical facts that address activities Sensus Healthcare assumes, plans, expects, believes, intends or anticipates and other similar expressions will, should or may occur in the future are forward-looking statements. The forward-looking statements are management’s beliefs based on currently available information as of the date of this conference call, November 3, 2022.
Sensus Healthcare undertakes no application to revise or update any forward-looking statements except as required by law. All forward-looking statements are subject to risks and uncertainties, including the continuation of severity of the COVID-19 pandemic and its impact on sales and marketing, as described in the company’s Forms 10-K and 10-Q. During today’s conference call, references will be made to certain non-GAAP financial measures. Sensus believes these measures provide useful information for investors that they should not be considered as a substitute for GAAP nor should they be viewed as a substitute for operating results determined in accordance with GAAP. A reconciliation of non-GAAP to GAAP results is included in today’s financial results press release.
With that said, I’d like to turn the call over to Joe Sardano. Joe?
Joe Sardano
Thank you, Kim, and good afternoon, everyone. I am delighted to be reporting continued excellent execution of our growth strategy, strong financial performance evidenced by our very good year-over-year revenue growth and continued profitability. Our revenue of $9 million was up 64% over last year. In addition, we posted diluted earnings per share of $0.11 compared with $0.01 a year ago.